3 stories mentioning SHE:002923Updated 39d ago
Every FINWIRES story that references SHE:002923, newest first.
Zhuhai Rundu Pharmaceutical (SHE:002923) obtained drug registration from China's medical products regulator for 75- and 100-milligram dosages of diclofenac sodium sustained-release tablets.The drug is indicated for chronic arthritis, soft tissue rheumatic pain and acute mild to moderate pain, according to a Friday fling with the Shenzhen bourse.Shares of the pharmaceutical company closed 1% higher Friday.
China's drug regulator granted Zhuhai Rundu Pharmaceutical (SHE:002923) marketing approval for telmisartan, according to a Tuesday filing with the Shenzhen bourse.The drug is used in hypertension medication, the filing said.
Zhuhai Rundu Pharmaceutical (SHE:002923) obtained approval from China's National Medical Products Administration for the marketing of losartan potassium, according to a Shenzhen bourse filing on Wednesday.The drug is used for the treatment of primary hypertension and chronic heart failure.The pharmaceutical company's shares rose by less than 2% at the close.
